ask="5.95"
ask_size="100"
average_daily_volume="1479220"
bid="4.00"
bid_size="200"
book_value="0.21"
change="-0.13"
change_from_200_day_moving_average="0.19"
change_from_50_day_moving_average="-0.18"
change_from_52_week_high="-2.35"
change_From_52_week_low="2.28"
change_in_percent="-2.33%"
close="5.45"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.56"
ebitda="-113.37M"
eps_estimate_current_year="-1.45"
eps_estimate_next_quarter="-0.19"
eps_estimate_next_year="-0.61"
ex_dividend_date="N/A"
float_shares="71284000"
high="5.64"
high_52_weeks="7.80"
last_trade_date="2/10/2017"
last_trade_price="5.45"
last_trade_size="24364"
last_trade_time="4:00pm"
low="5.45"
low_52_weeks="3.17"
market_capitalization="577.48M"
moving_average_200_day="5.26"
moving_average_50_day="5.63"
name="Keryx Biopharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.21"
open="5.64"
pe_ratio="N/A"
peg_ratio="-0.03"
percent_change_from_200_day_moving_average="+3.68%"
percent_change_from_50_day_moving_average="-3.12%"
percent_change_from_52_week_high="-30.13%"
percent_change_from_52_week_low="+71.92%"
previous_close="5.58"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="26.83"
price_per_sales="20.94"
revenue="28.23M"
shares_outstanding="105960000"
short_ratio="15.67"
stock_exchange="NCM"
symbol="KERX"
volume="684724"
weeks_range_52="3.17 - 7.80"
